洲际航天科技 01725.HK 深 沪
已收盘 08-15 16:10:00
1.350
+0.120
+9.76%
华盛通- 最 高1.360
- 今 开1.240
- 成交量 2342.99万股
- 最 低 1.210
- 昨 收 1.230
- 总市值 6.80亿
- 52周最高 2.970
- 市盈率 静 --
- 换手率 4.65%
- 52周最低 0.480
- 委 比 -5.58%
- 总股本 5.04亿
- 历史最高 1.390
- 量 比 0.97
- 振 幅 12.20%
- 历史最低 0.480
- 每 手 200
- 风险率 0.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Shuttle Pharma Provides Second Quarter 2025 Corporate Update
Shuttle Pharmaceuticals provided an update on its Phase 2 clinical trial for Ropidoxuridine in glioblastoma, achieving 63% patient enrollment and 72% completing all cycles with good tolerability. The company ended Q2 with $4.8 million in cash following a $4.25 million private placement and completed a reverse stock split. Board changes include George Scorsis as Chairman and Christopher Cooper joining the board. Ropidoxuridine, a radiation sensiti...
08-14 20:05
GT Biopharma Reports Second Quarter 2025 Financial Results
GT Biopharma, Inc. reported that its GTB-3650 TriKE® Phase 1 trial has completed dosing for Cohort 1 and 2, treating four patients, and has advanced into Cohort 3. Initial Phase 1 data is expected in late 2025. The company anticipates submitting an IND application for GTB-5550 in Q4 2025. As of June 30, 2025, GT Biopharma had $5.3 million in cash, sufficient to fund operations into Q1 2026. The company noted a decrease in R&D and SG&A expenses, r...
08-14 20:05
Credit Acceptance Named to 2025 Crain's Fast 50 List
Credit Acceptance Corporation has been named to the 2025 Crain’s Fast 50 list for the ninth time, highlighting its rapid growth in metro Detroit. Over the past five years, the company’s revenue increased by 29.5% to $2.2 billion in 2024. Jay Martin, Chief Financial Officer, emphasized the company’s unique approach to helping automobile dealers finance consumers regardless of credit history, creating success for dealers, consumers, and communities...
08-14 20:02
智通港股解盘 | 资金积极入市抢筹 腾讯控股(00700)创四年新高
中美关税延期，背后折射的就是美国在退让，资本市场都能看懂。因此，今天两地市场直接大幅上涨，A股沪指涨0.48%，创近4年新高，总成交额超2.1万亿，港股也大涨2.58%，量能放大到了2840亿，可见资金入场积极。
08-13 20:39
Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
Mainz Biomed's ColoAlert®, a non-invasive colorectal cancer (CRC) screening test, has received regulatory approval from Swissmedic, allowing its distribution in Switzerland. Targeting individuals aged 50-74, a group of around 2.8 million people, ColoAlert® aims to address the low participation rate in CRC screening programs (below 50%) and support national health goals. The approval follows a partnership with a local Swiss laboratory, enabling br...
08-13 12:01
智通港股解盘 | 锂矿反内卷全线飙升 美国出口管制政策出现重大转变
近期A股走势明显强于港股，沪指继续往上拓展空间，看样子是要往3700点走，港股则小幅震荡，收盘涨0.19%。
08-11 20:14
REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
<p>Tevogen Bio Holdings Inc. (Nasdaq: TVGN) has rapidly evolved into a dynamic enterprise expanding into artificial intelligence through Tevogen.AI. The company's mission is to deliver clinically impactful, economically accessible therapies by leveraging cutting-edge science and technology. Tevogen emphasizes social responsibility, patient affordability, and cost efficiency. Recent advancements include the successful launch of their proprietary A...
08-11 13:28
RedCloud Delivers Stellar Year-Over-Year Customer Growth In H1 With Positive Retailer Purchasing Behavior
RedCloud Holdings plc在2025年上半年实现了显著的客户增长，零售商数量增长110%至68,089，分销商增长136%至1,017。RedCloud的RedAI平台通过多样化数据集增强了市场洞察力，而Red101应用显示多品牌订单增加214%，显示供应链的透明度和灵活性提升。公司对未来增长充满信心，特别是结合TradeX计划提升FMCG贸易效率。
08-11 12:00
